Initial clinical experience with the GORE® CARDIOFORM ASD occluder for transcatheter atrial septal defect closure.

@article{Hemptinne2017InitialCE,
  title={Initial clinical experience with the GORE® CARDIOFORM ASD occluder for transcatheter atrial septal defect closure.},
  author={Quentin de Hemptinne and E Mitchell Horlick and Mark D. Osten and Xavier Mill{\'a}n and Victor-Xavier Tadros and Michele Pighi and Francisco Gonzalez Barlatey and Sami M A Alnasser and J. Mir{\'o} and Anita W. Asgar and R{\'e}da Ibrahim},
  journal={Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions},
  year={2017},
  volume={90 3},
  pages={495-503}
}
OBJECTIVES To report the initial clinical experience with a novel atrial septal defect (ASD) closure device, the GORE® CARDIOFORM ASD Occluder (GCO). BACKGROUND Transcatheter closure has become the treatment of choice for secundum ASD. A wide range of occluder devices are available, but concern has been raised about the risk of cardiac erosion associated with rigid devices and future access to the left atrium METHODS: Retrospective chart review of patients treated with the GCO at three… CONTINUE READING